FDA Grants New Indication for Darzalex Faspro: Newly Diagnosed Light Chain Amyloidosis

The FDA granted a new indication for daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen) used with ...

JANUARY 21, 2021